NCT02766608: A reported trial by Pearl Therapeutics, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02766608 |
|---|---|
| Title | A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort® Turbuhaler®, as an Active Control, on Lung Function Over a 24-Week Treatment Period in Subjects With Moderate to Very Severe COPD |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | May 31, 2016 |
| Completion date | Dec. 1, 2017 |
| Required reporting date | Dec. 1, 2018, midnight |
| Actual reporting date | Nov. 30, 2018 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |